Upcoming event
17th European Multidisciplinary Congress on Urological Cancer
Back

First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (Pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC)

  • Necchi A. 1,
  • Bandini M. 2,
  • Gallina A. 2,
  • Bianchi M. 2,
  • Raggi D. 1,
  • Fare' E. 1,
  • Messina A. 1,
  • Chung J. 3,
  • Ali S. 3,
  • Ross J. 3,
  • Anichini A. 1,
  • Colecchia M. 1,
  • Gandaglia G. 2,
  • Fossati N. 2,
  • Scuderi S. 2,
  • Pederzoli F. 2,
  • Salonia A. 2,
  • Colombo R. 2,
  • Briganti A. 2,
  • Montorsi F. 2
1 Fondazione IRCCS Istituto Nazionale dei Tumori, Dept. of Medical Oncology, Milan, Italy 2 Urological Research Institute (URI), IRCCS San Raffaele Hospital, Dept. of Urology, Milan, Italy 3 Foundation Medicine, Cambridge, United States of America

Publication: March 2019